Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday’s session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses.
Where Today's News Shapes Tomorrow
Where Today's News Shapes Tomorrow